Kevin W. Garey

This study profiles carbon metabolism in C. difficile clinical isolates, revealing lineage-specific metabolic capabilities and divergence in two emerging ribotypes.

This study compares the microbiome effects of ibezapolstat and other antibiotics in humanized mice, finding that ibezapolstat and fidaxomicin had smaller impacts on gut microbiome diversity than vancomycin and metronidazole.